Specialty Chemicals & Gases

Acutaas Chemicals

AMIORGNSESmall Cap

Live₹2,400syncing…

Specialty chemicals (formerly Ami Organics) with electronics chemistry initiatives.

Market Cap

₹9.0k cr

Price

2400

1Y 60%

Direct exposure

35/100

0–100 directness

Hold / Watchlist

Fundamental

68/ 100

B+

Quality of growth, returns, cash conversion and balance sheet

Technical (TQ-100)

78/ 100

Trend, momentum, volume and relative strength composite

Valuation

36/ 100

Higher = cheaper vs peers and own history

Final composite

62/ 100

Blended decision input

Data transparency

What's real, what's pending, on this page

Financials pending

✓ Real / verified

· Live price, day change, market cap — NSE direct
· 1Y OHLCV, RSI(14), 50/200 DMA, 1M/3M/1Y returns, RS vs Nifty — computed from real NSE OHLCV
· Sector P/E — NSE direct
· Promoter %, pledge %, MF/FII/public split, 9-quarter history — Trendlyne
· Earnings call AI summaries — Trendlyne (where available)
· Technical (TQ-100) score — computed from real OHLCV

⚠ Pending real Trendlyne extraction

· Revenue, EBITDA, PAT, OCF, Capex, FCF, net debt — pending
· Top-card ratios + valuation multiples — pending real recompute
· Fundamental score + final composite + decision — pending real recompute
· Segment classification + semicon directness score — analyst seed
· Bull/bear case + monitorables (curated thesis) — analyst seed
· Governance risk score (seed) — being replaced by AI-agent assessment
· Synthesized 5Y forecast removed entirely (was inaccurate)

Real financials extracted for 42 of 45 companies. This company is in the remaining 3 — Trendlyne entry not found (RIRL / AMIORG / ASMS). See /data-sources for full provenance.

Acutaas Chemicals · AMIORG

₹2,400-46.66% over 6M

Price50 DMA200 DMA

RSI (14)

Momentum oscillator · 6M view

Volume (60D)

Fundamental score (SageOne 100)

64/ 100B

Growth 20 / Margin 15 / ROC 20 / Cash 15 / Leverage 10 / Reinvestment 8 / Accounting 7 / Governance 5 minus red flags (capped -20).

Base 64

Growth quality/ 20

16.7

Rev 1Y 26.0% · 3Y CAGR 24.0%

Margin & profitability/ 15

8.7

EBITDA 18.0% · PAT 11.0%

Return on capital/ 20

9.9

ROCE 18% · ROE 14%

Cash flow quality/ 15

6.4

OCF/EBITDA 50% · FCF yield 0.6%

Leverage discipline/ 10

9.0

Net Debt/EBITDA 0.30x

Reinvestment runway/ 8

4.6

ROCE × retention proxy

Accounting quality/ 7

4.4

OCF conversion proxy

Governance/ 5

3.9

Pledge 0.0% · Risk 22/100

⚠ Pending — Trendlyne entry not found for this ticker.

Technical score (TQ-100)

87/ 100A+

Computed from real 1Y OHLCV pulled from NSE direct: trend, momentum, volume, RS vs Nifty, MA cluster, mean reversion, volatility, patterns minus red flags.

Base 87

Trend structure/ 20

19.4

Above 200DMA · -8% from 52W high

Momentum velocity/ 15

15.0

RSI(14) 64 · 1M 5.0%

Volume dynamics/ 15

8.3

Bucket: Small Cap

Relative strength/ 15

15.0

RS vs Nifty 38%

MA cluster/ 10

10.0

200DMA + 1Y trend confirmation

Mean-reversion runway/ 10

7.0

RSI(14) 64; ideal 50-60

Volatility profile/ 8

4.8

Bucket: Small Cap

Pattern integrity/ 7

7.0

Trend continuation proxy

AI research agents

Re-classify segment exposure and re-assess governance risk by running fresh AI agents on the latest data. Results cache to data/agents.json.

Segment classifier

Maps to value-chain segments + computes 0-100 directness

Seed: Specialty Chemicals & Gases · 35/100

Governance assessor

Forensic-accounting flags + 0-100 risk score

Seed: 22/100 risk

AI thesis

Generates a fresh thesis grounded in this company's data. Wires to Anthropic when ANTHROPIC_API_KEY is set, otherwise returns a deterministic mock.

Curated thesis

Analyst-set bull, bear and monitorables · use AI thesis above for a fresh take

Strong technical setup, improving fundamentals, electronics chemistry as upside option.

Bull case

+Improving margin profile
+Strong technical setup
+Electronics chemistry option

Bear case

−Valuation full
−Customer concentration
−Capex utilization

Key monitorables

Electronics chemistry tractionMargin pathOrder book

Semiconductor exposure

How direct, how visible

Primary segment

Specialty Chemicals & Gases

All segments

Specialty Chemicals & Gases

Exposure type

Ancillary

Policy beneficiary

Possible

Import substitution

Medium / Low

Governance risk score

22/100 (lower = better)

Financial snapshot

Latest reported metrics · mock data, ready for live financials

Rev growth (1Y)

26.0%

Rev CAGR (3Y)

24.0%

EBITDA margin

18.0%

PAT margin

11.0%

ROCE

18%

ROE

14%

OCF / EBITDA

50%

Net Debt / EBITDA

0.3x

Promoter holding

52.4%

Promoter pledge

0.0%

Valuation

P/E (TTM)

50.0

Forward P/E

36.0

EV/EBITDA

30.0

EV/Sales

5.5

P/B

6.0

FCF Yield

0.6%

Dividend Yield

0.20%

Hist. percentile

65%

Peer percentile

65%

Technicals

RSI(14)

1M return

5.0%

1Y return

60%

From 52W high

-8%

RS vs Nifty

38%

>200 DMA

Yes

Annual financials

Trendlyne extraction pending for this company

Pending

Real audited annuals not yet ingested for this company. 25 of 45 companies are covered; this one is queued for the next refresh batch. Synthesized fallback removed — only real numbers will be displayed here.

Management quality

Capital allocation, debt discipline, alignment, governance composite. Computed from disclosed metrics.

Capital allocation

Acceptable returns on capital, room for sharper allocation.

ROCE 18%, div yield 0.2%

Promoter holding

Promoter has strong skin in the game.

52.4%

Promoter pledge

No pledging — cleanest signal.

0.0%

Debt discipline

Comfortable leverage band.

Net Debt/EBITDA 0.30x

Cash conversion

Acceptable conversion; track working capital cycles.

OCF/EBITDA 50%

Governance composite

Some watchpoints; nothing disqualifying.

22/100 risk

Variant perception

What the market is pricing in versus our read, and what would invalidate the thesis.

What the market is pricing in

Steady but unspectacular execution. Multiples reflect mid-pack expectations.

What we think it's missing

Consensus appears reasonable. Look for thesis-changing catalysts (margin inflection, new customer wins, segment mix shift) rather than narrative re-rating alone.

Thesis killers

×Working capital blowout disclosed in next quarterly result

References

Wire to live data sources in production

NSE filings Screener BSE corporate filings Annual report (latest)Concall transcript (latest)Investor presentation